nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP3A4—Esomeprazole—Barrett's esophagus	0.294	0.397	CbGbCtD
Perhexiline—CYP2D6—Omeprazole—Barrett's esophagus	0.272	0.368	CbGbCtD
Perhexiline—CYP3A4—Omeprazole—Barrett's esophagus	0.173	0.234	CbGbCtD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.0252	0.33	CbGpPWpGaD
Perhexiline—Optic neuritis—Esomeprazole—Barrett's esophagus	0.0122	0.0661	CcSEcCtD
Perhexiline—Optic neuritis—Omeprazole—Barrett's esophagus	0.0122	0.0661	CcSEcCtD
Perhexiline—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.0075	0.0407	CcSEcCtD
Perhexiline—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.0075	0.0407	CcSEcCtD
Perhexiline—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00558	0.0303	CcSEcCtD
Perhexiline—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00558	0.0303	CcSEcCtD
Perhexiline—Diplopia—Omeprazole—Barrett's esophagus	0.00545	0.0295	CcSEcCtD
Perhexiline—Diplopia—Esomeprazole—Barrett's esophagus	0.00545	0.0295	CcSEcCtD
Perhexiline—Muscular weakness—Esomeprazole—Barrett's esophagus	0.0048	0.026	CcSEcCtD
Perhexiline—Muscular weakness—Omeprazole—Barrett's esophagus	0.0048	0.026	CcSEcCtD
Perhexiline—Weight decreased—Omeprazole—Barrett's esophagus	0.00426	0.0231	CcSEcCtD
Perhexiline—Weight decreased—Esomeprazole—Barrett's esophagus	0.00426	0.0231	CcSEcCtD
Perhexiline—Hepatitis—Omeprazole—Barrett's esophagus	0.00377	0.0204	CcSEcCtD
Perhexiline—Hepatitis—Esomeprazole—Barrett's esophagus	0.00377	0.0204	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.00366	0.0478	CbGpPWpGaD
Perhexiline—Flushing—Omeprazole—Barrett's esophagus	0.0035	0.019	CcSEcCtD
Perhexiline—Flushing—Esomeprazole—Barrett's esophagus	0.0035	0.019	CcSEcCtD
Perhexiline—Tension—Omeprazole—Barrett's esophagus	0.00322	0.0174	CcSEcCtD
Perhexiline—Tension—Esomeprazole—Barrett's esophagus	0.00322	0.0174	CcSEcCtD
Perhexiline—Nervousness—Omeprazole—Barrett's esophagus	0.00319	0.0173	CcSEcCtD
Perhexiline—Nervousness—Esomeprazole—Barrett's esophagus	0.00319	0.0173	CcSEcCtD
Perhexiline—Tremor—Omeprazole—Barrett's esophagus	0.00307	0.0167	CcSEcCtD
Perhexiline—Tremor—Esomeprazole—Barrett's esophagus	0.00307	0.0167	CcSEcCtD
Perhexiline—Shock—Esomeprazole—Barrett's esophagus	0.00263	0.0143	CcSEcCtD
Perhexiline—Shock—Omeprazole—Barrett's esophagus	0.00263	0.0143	CcSEcCtD
Perhexiline—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00259	0.014	CcSEcCtD
Perhexiline—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00259	0.014	CcSEcCtD
Perhexiline—Anorexia—Esomeprazole—Barrett's esophagus	0.00255	0.0138	CcSEcCtD
Perhexiline—Anorexia—Omeprazole—Barrett's esophagus	0.00255	0.0138	CcSEcCtD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00249	0.0325	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00249	0.0325	CbGpPWpGaD
Perhexiline—Insomnia—Omeprazole—Barrett's esophagus	0.00242	0.0131	CcSEcCtD
Perhexiline—Insomnia—Esomeprazole—Barrett's esophagus	0.00242	0.0131	CcSEcCtD
Perhexiline—Paraesthesia—Omeprazole—Barrett's esophagus	0.0024	0.013	CcSEcCtD
Perhexiline—Paraesthesia—Esomeprazole—Barrett's esophagus	0.0024	0.013	CcSEcCtD
Perhexiline—Decreased appetite—Omeprazole—Barrett's esophagus	0.00233	0.0126	CcSEcCtD
Perhexiline—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00233	0.0126	CcSEcCtD
Perhexiline—Fatigue—Esomeprazole—Barrett's esophagus	0.00231	0.0125	CcSEcCtD
Perhexiline—Fatigue—Omeprazole—Barrett's esophagus	0.00231	0.0125	CcSEcCtD
Perhexiline—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00219	0.0119	CcSEcCtD
Perhexiline—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00219	0.0119	CcSEcCtD
Perhexiline—Urticaria—Esomeprazole—Barrett's esophagus	0.00213	0.0115	CcSEcCtD
Perhexiline—Urticaria—Omeprazole—Barrett's esophagus	0.00213	0.0115	CcSEcCtD
Perhexiline—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00212	0.0115	CcSEcCtD
Perhexiline—Abdominal pain—Omeprazole—Barrett's esophagus	0.00212	0.0115	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.0021	0.0274	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.002	0.0261	CbGpPWpGaD
Perhexiline—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00197	0.0257	CbGpPWpGaD
Perhexiline—CPT2—PPARA activates gene expression—PPARG—Barrett's esophagus	0.00195	0.0255	CbGpPWpGaD
Perhexiline—Asthenia—Esomeprazole—Barrett's esophagus	0.00192	0.0104	CcSEcCtD
Perhexiline—Asthenia—Omeprazole—Barrett's esophagus	0.00192	0.0104	CcSEcCtD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.00191	0.0249	CbGpPWpGaD
Perhexiline—Dizziness—Esomeprazole—Barrett's esophagus	0.00177	0.0096	CcSEcCtD
Perhexiline—Dizziness—Omeprazole—Barrett's esophagus	0.00177	0.0096	CcSEcCtD
Perhexiline—Vomiting—Esomeprazole—Barrett's esophagus	0.0017	0.00923	CcSEcCtD
Perhexiline—Vomiting—Omeprazole—Barrett's esophagus	0.0017	0.00923	CcSEcCtD
Perhexiline—Rash—Omeprazole—Barrett's esophagus	0.00169	0.00915	CcSEcCtD
Perhexiline—Rash—Esomeprazole—Barrett's esophagus	0.00169	0.00915	CcSEcCtD
Perhexiline—Dermatitis—Omeprazole—Barrett's esophagus	0.00169	0.00914	CcSEcCtD
Perhexiline—Dermatitis—Esomeprazole—Barrett's esophagus	0.00169	0.00914	CcSEcCtD
Perhexiline—Headache—Esomeprazole—Barrett's esophagus	0.00168	0.00909	CcSEcCtD
Perhexiline—Headache—Omeprazole—Barrett's esophagus	0.00168	0.00909	CcSEcCtD
Perhexiline—Nausea—Omeprazole—Barrett's esophagus	0.00159	0.00862	CcSEcCtD
Perhexiline—Nausea—Esomeprazole—Barrett's esophagus	0.00159	0.00862	CcSEcCtD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00158	0.0206	CbGpPWpGaD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00156	0.0203	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00146	0.019	CbGpPWpGaD
Perhexiline—CPT1A—PPARA activates gene expression—PPARG—Barrett's esophagus	0.00135	0.0177	CbGpPWpGaD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.00132	0.0173	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.00131	0.0172	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00128	0.0167	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00113	0.0148	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00113	0.0148	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.0011	0.0143	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00108	0.0141	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTGES—Barrett's esophagus	0.000935	0.0122	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—TP53—Barrett's esophagus	0.000919	0.012	CbGpPWpGaD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.000911	0.0119	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000889	0.0116	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000834	0.0109	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000818	0.0107	CbGpPWpGaD
Perhexiline—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000783	0.0102	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.00078	0.0102	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000717	0.00937	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP26A1—Barrett's esophagus	0.000709	0.00926	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000708	0.00925	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP26A1—Barrett's esophagus	0.00068	0.00888	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00067	0.00876	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTGES—Barrett's esophagus	0.000648	0.00847	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000581	0.0076	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000523	0.00684	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—SLC9A1—Barrett's esophagus	0.000511	0.00667	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP26A1—Barrett's esophagus	0.000491	0.00642	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000472	0.00617	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000466	0.00609	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000412	0.00538	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TP53—Barrett's esophagus	0.000391	0.0051	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000372	0.00486	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000363	0.00474	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SLC9A1—Barrett's esophagus	0.000354	0.00463	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000309	0.00403	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000305	0.00398	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000285	0.00373	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PPARG—Barrett's esophagus	0.000233	0.00305	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTGS2—Barrett's esophagus	0.000183	0.0024	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PPARG—Barrett's esophagus	0.000162	0.00211	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGES—Barrett's esophagus	0.000153	0.002	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTGS2—Barrett's esophagus	0.000127	0.00166	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	0.000116	0.00152	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGES—Barrett's esophagus	0.000107	0.00139	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	8.38e-05	0.00109	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	8.08e-05	0.00106	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGES—Barrett's esophagus	6.97e-05	0.00091	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	5.82e-05	0.000761	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	5.28e-05	0.00069	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PPARG—Barrett's esophagus	3.82e-05	0.0005	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	3.81e-05	0.000497	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	3.01e-05	0.000393	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PPARG—Barrett's esophagus	2.66e-05	0.000347	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	2.09e-05	0.000273	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PPARG—Barrett's esophagus	1.74e-05	0.000227	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.37e-05	0.000179	CbGpPWpGaD
